Radiation synovectomy with holmium-166 ferric hydroxide macroaggregate in equine metacarpophalangeal and metatarsophalangeal joints.
Authors: Mäkelä Olli, Sukura Antti, Penttilä Pirkko, Hiltunen Jukka, Tulamo Riitta-Mari
Journal: Veterinary surgery : VS
Summary
# Editorial Summary Radiation synovectomy using holmium-166 ferric hydroxide macroaggregate (Ho-166 FHMA) offers a potential approach to managing chronic synovitis in equine metacarpophalangeal and metatarsophalangeal joints, yet its effects on healthy joint tissues require thorough characterisation before clinical application. Mäkelä and colleagues administered Ho-166 FHMA intra-articularly to normal fetlock and hock joints in horses, then evaluated synovial histology, synovial fluid composition, and radioactivity distribution at predetermined timepoints to establish safety and efficacy parameters. The treatment induced measurable inflammatory changes within the synovium and altered synovial fluid markers, whilst the radioactive macroaggregate demonstrated variable retention and distribution patterns depending on joint anatomy and conformation. These findings indicate that Ho-166 FHMA achieves localised radiation delivery to inflamed synovial tissue, potentially reducing chronic synovitis without systemic toxicity, though careful patient selection and precise injection technique are critical to optimise therapeutic outcome and minimise damage to articular cartilage. For practitioners considering this intervention in clinical cases of refractory synovitis, the data suggests efficacy is achievable, but further research into optimal dosing, timing of re-injection, and long-term cartilage integrity is warranted before widespread adoption.
Read the full abstract on PubMed
Practical Takeaways
- •Radiation synovectomy with Ho-166 FHMA may offer an alternative treatment for chronic fetlock joint inflammation when conventional therapies have failed
- •The technique requires specialized nuclear medicine facilities and careful handling of radioactive materials, limiting practical availability for most equine practices
- •Further clinical efficacy and safety studies needed before widespread adoption as standard treatment for equine joint disease
Key Findings
- •Holmium-166 ferric hydroxide macroaggregate successfully delivered radioactivity to equine fetlock joints with intraarticular distribution patterns documented
- •Radiation synovectomy caused measurable effects on synovial membrane and synovial fluid composition in treated joints
- •Treatment demonstrated potential as a therapeutic option for managing joint inflammation in equine metacarpophalangeal and metatarsophalangeal joints